not tagged
amgen
['amgenoncology', 'amgen']
determining a patient s #mrd (measurable residual disease) status can help drive treatment choices. join at #eha2022 as we continue to explore innovative approaches with the goal of eradicating mrd across multiple hematologic malignancies.
Advancing oncology at the speed of life™. Tweets intended for U.S. audience. See our Community Guidelines: https://t.co/WUbqtYa6KT.